PHLPP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.482400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.791400E-01
Normal-vs-Stage2
6.858600E-01
Normal-vs-Stage3
1.939830E-01
Normal-vs-Stage4
7.031200E-01
Stage1-vs-Stage2
2.909400E-01
Stage1-vs-Stage3
8.430400E-02
Stage1-vs-Stage4
3.784400E-01
Stage2-vs-Stage3
5.44359999965494E-07
Stage2-vs-Stage4
9.321800E-01
Stage3-vs-Stage4
2.170800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.515600E-01
Normal-vs-AfricanAmerican
5.038400E-01
Normal-vs-Asian
7.152200E-02
Caucasian-vs-AfricanAmerican
4.536200E-02
Caucasian-vs-Asian
5.222700E-03
AfricanAmerican-vs-Asian
7.241800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.423200E-01
Normal-vs-Female
7.714400E-01
Male-vs-Female
8.873600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.903800E-01
Normal-vs-Age(41-60Yrs)
7.562800E-01
Normal-vs-Age(61-80Yrs)
5.141800E-01
Normal-vs-Age(81-100Yrs)
3.992200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.493600E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.391600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.751560E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.839300E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.41129999995127E-06
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.119710E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.595800E-01
Normal-vs-Daily Drinker
4.478400E-01
Normal-vs-Weekly Drinker
8.567200E-01
Normal-vs-Occasional Drinker
7.758800E-01
Normal-vs-Social Drinker
8.860000E-01
Non Drinker-vs-Daily Drinker
7.058800E-01
Non Drinker-vs-Weekly Drinker
3.055600E-01
Non Drinker-vs-Occasional Drinker
1.384220E-01
Non Drinker-vs-Social Drinker
7.625500E-02
Daily Drinker-vs-Weekly Drinker
4.223400E-01
Daily Drinker-vs-Occasional Drinker
3.469000E-01
Daily Drinker-vs-Social Drinker
1.269580E-01
Weekly Drinker-vs-Occasional Drinker
9.597200E-01
Weekly Drinker-vs-Social Drinker
5.891200E-01
Occasional Drinker-vs-Social Drinker
4.668200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.664200E-01
Normal-vs-Grade 2
3.316000E-01
Normal-vs-Grade 3
2.297200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.931650E-01
Grade 1-vs-Grade 3
6.124200E-01
Grade 1-vs-Grade 4
2.664200E-01
Grade 2-vs-Grade 3
3.648000E-01
Grade 2-vs-Grade 4
3.316000E-01
Grade 3-vs-Grade 4
2.297200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.576000E-01
Normal-vs-NonDiabetic
6.673600E-01
Diabetic-vs-NonDiabetic
6.305800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.859800E-01
Normal-vs-NoPancreatitis
6.607600E-01
Pancreatitis-vs-NoPancreatitis
9.802000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.926000E-01
Normal-vs-N1
7.173800E-01
N0-vs-N1
8.923200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.601200E-01
Normal-vs-TP53-NonMutant
9.759600E-01
TP53-Mutant-vs-TP53-NonMutant
8.222700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
